<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Microbiologic diagnosis of Bartonella infections
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Microbiologic diagnosis of Bartonella infections
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Microbiologic diagnosis of Bartonella infections
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David H Spach, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kimberly E Hanson, MD, MHS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Roy M Gulick, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 20, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H28105014">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Bartonella
         </em>
         infections cause multiple distinct syndromes that can have serious morbidity and mortality.
        </p>
        <p>
         This topic will address the microbiologic tests available for
         <em>
          Bartonella henselae
         </em>
         and
         <em>
          Bartonella quintana
         </em>
         infections. The diagnostic approach and utilization of these tests for distinct bartonellosis syndromes is discussed elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease", section on 'Diagnostic tests'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">
          "Endocarditis caused by Bartonella", section on 'Evaluation and Diagnosis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">
          "Bartonella infections in people with HIV", section on 'Diagnostic challenges'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5517.html" rel="external">
          "Bartonella quintana infections: Clinical features, diagnosis, and treatment", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Diagnostic tests for South American bartonellosis (Oroya fever and verruga peruana) due to
         <em>
          Bartonella bacilliformis
         </em>
         are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5516.html" rel="external">
          "South American bartonellosis: Oroya fever and verruga peruana", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28105029">
         <span class="h1">
          APPROACH TO DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of
         <em>
          Bartonella
         </em>
         infections can be challenging because of limited accuracy of microbiologic testing and the difficulty in culturing this organism. More than one diagnostic test is generally required to identify and confirm active
         <em>
          Bartonella
         </em>
         infection.
        </p>
        <p>
         The approach to diagnosis varies based on the clinical syndrome. With the exception of cat-scratch disease, the microbiologic diagnosis usually requires serologic testing combined with one or more definitive nonserologic tests (eg, culture, polymerase chain reaction [PCR], histopathology). For cat-scratch disease, the diagnosis is typically based on a characteristic clinical presentation coupled with a history of cat or flea exposure, with serologic testing mainly used to support the diagnosis. Further information regarding the optimal diagnostic approach for specific bartonellosis syndromes is found elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease", section on 'Diagnostic tests'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">
          "Endocarditis caused by Bartonella", section on 'Evaluation and Diagnosis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">
          "Bartonella infections in people with HIV", section on 'Diagnostic challenges'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5517.html" rel="external">
          "Bartonella quintana infections: Clinical features, diagnosis, and treatment", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3776656002">
         <span class="h1">
          SEROLOGIC TESTS
         </span>
        </p>
        <p class="headingAnchor" id="H1243299947">
         <span class="h2">
          Role of serology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serologic testing is not a definitive test for
         <em>
          Bartonella
         </em>
         infection, but it is often used as an initial test to raise or lower the likelihood of infection. A positive serologic test (eg, ≥1:256) coupled with strong clinical suspicion is often used to make a presumptive diagnosis. Whenever possible, however, serologic tests should be combined with a definitive nonserologic test (eg, polymerase chain reaction [PCR] or culture) to optimize the accuracy of the diagnosis. The exception to this is cat-scratch disease, which is primarily a clinical diagnosis. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above and
         <a class="local">
          'Definitive diagnostic tests'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease", section on 'Approach to diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1234279709">
         <span class="h2">
          Components of serology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most laboratories measure separate immunoglobulin (Ig) antibody levels for IgM and IgG and report separate results for
         <em>
          B. henselae
         </em>
         and
         <em>
          B. quintana
         </em>
         . However, differentiation of
         <em>
          B. henselae
         </em>
         from
         <em>
          B. quintana
         </em>
         may be unreliable due to serologic cross-reactivity, especially for IgG assays [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         In the United States, serologic tests for
         <em>
          Bartonella
         </em>
         are available through several commercial laboratories, some state health laboratories, and the Centers for Disease Control and Prevention (CDC). Two serologic methods, indirect fluorescence assay (IFA) and enzyme immunosorbent assay (EIA), have been developed; most laboratories use the IFA assay.
        </p>
        <p class="headingAnchor" id="H3890274995">
         <span class="h2">
          Interpreting serologic results
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clearly defined, uniform cut-off titers for a positive
         <em>
         </em>
         serologic result do not exist because the predictive values of titers vary in relation to different types of
         <em>
          Bartonella
         </em>
         infections. In addition, subtle differences exist between IFA assays used by different labs [
         <a href="#rid2">
          2
         </a>
         ]. Nevertheless, the cut-offs detailed in the sections that follow are generally consistent with those reported by most laboratories.
        </p>
        <p class="headingAnchor" id="H1371804147">
         <span class="h3">
          Positive serologic results
         </span>
         <span class="headingEndMark">
          —
         </span>
         For most labs, the cut-off for IgG positivity is ≥1:256, which strongly suggests active or recent infection. For endocarditis, a higher cut-off (eg, ≥1:1024) is typically used since most persons with
         <em>
          Bartonella
         </em>
         endocarditis have very high serologic titers.
        </p>
        <p>
         At least 5 percent of the general population has positive IgG titers to
         <em>
          Bartonella
         </em>
         , so false-positive results can occur, most often from prior infection [
         <a href="#rid3">
          3-6
         </a>
         ]. Other causes include cross-reactivity with other pathogens and recent receipt of therapeutic immunoglobulin.
        </p>
        <p>
         A positive IgM result is strongly suggestive of acute or very recent infection, but IgM production in infected individuals is brief and laboratory detection of IgM can be elusive. The cut-off for IgM positivity varies between labs, and false-positive IgM results are less common than with IgG assays.
        </p>
        <p class="headingAnchor" id="H1983275049">
         <span class="h3">
          Negative or equivocal IgG results
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although serology cannot rule out the possibility of bartonellosis, a negative IgG result (&lt;1:64) substantially reduces the likelihood of bartonellosis, especially when clinical suspicion is low or clinical findings are nonspecific (eg, fever of unknown origin). The significance of equivocal results (eg, 1:64 and 1:128) is uncertain.
        </p>
        <p>
         If clinical suspicion remains high despite negative or equivocal initial IgG serologic tests, we suggest the following serologic approach:
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If titers are equivocal or close to the transition point between positive and negative, we suggest repeat testing in 10 to 14 days. If the subsequent test is positive, active or recent infection is likely (see
         <a class="local">
          'Positive serologic results'
         </a>
         above). Persistently detectable low-level titers that are not high enough to meet the cut-off for positivity may suggest past resolved infection or a false-positive test from cross-reactive antibodies.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For individuals who are suspected of having acute bartonellosis (eg, cat-scratch disease, trench fever), we suggest performing a final serologic test six weeks after onset of symptoms because antibodies often take six weeks to rise to detectable levels [
         <a href="#rid7">
          7
         </a>
         ]. A fourfold rise in titer is suggestive of recent infection, especially if the second titer is ≥1:256.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If serologic testing remains negative or equivocal after serial testing and clinical suspicion remains high, definitive nonserologic tests should be pursued. (See
         <a class="local">
          'Definitive diagnostic tests'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Possible explanations for persistently negative or equivocal serology in actively infected individuals include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Immunosuppressed individuals, including persons with HIV who have a low CD4 cell count, may be unable to produce antibodies at detectable levels [
         <a href="#rid7">
          7-9
         </a>
         ]. Details regarding serology in people with HIV are found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">
          "Bartonella infections in people with HIV", section on 'Diagnostic challenges'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         IgG titers may have suboptimal sensitivity for certain bartonellosis syndromes like cat-scratch disease [
         <a href="#rid10">
          10,11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Effective early antibiotic therapy for
         <em>
          Bartonella
         </em>
         may blunt antibody production, thereby causing negative or equivocal test results.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3797074808">
         <span class="h1">
          DEFINITIVE DIAGNOSTIC TESTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Definitive diagnosis of bartonellosis generally requires a positive culture or polymerase chain reaction (PCR) test or a biopsy with histopathology and Warthin-Starry (WS) staining that has findings consistent with
         <em>
          Bartonella
         </em>
         infection.
        </p>
        <p class="headingAnchor" id="H2420521910">
         <span class="h2">
          Optimal specimens
         </span>
         <span class="headingEndMark">
          —
         </span>
         The best type of sample to make a definitive diagnosis of bartonellosis primarily depends on the clinical syndrome and can be found elsewhere. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For some bartonellosis syndromes (eg, bacillary angiomatosis), obtaining a tissue biopsy for histopathology with WS staining is the optimal approach for making a definitive diagnosis. We also suggest performing PCR testing and culture on fresh tissue samples. The tissue samples should be sent to the microbiology and pathology laboratories in a sterile container. (See
         <a class="local">
          'Histopathology'
         </a>
         below and
         <a class="local">
          'Polymerase chain reaction'
         </a>
         below and
         <a class="local">
          'Culture'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For bacteremic syndromes (eg, endocarditis, contemporary
         <em>
          B. quintana
         </em>
         infection), blood samples can be tested by PCR or culture, although sensitivity varies substantially depending on the clinical syndrome. (See
         <a class="local">
          'Polymerase chain reaction'
         </a>
         below and
         <a class="local">
          'Culture'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H931398674">
         <span class="h2">
          Histopathology
         </span>
        </p>
        <p class="headingAnchor" id="H1544325993">
         <span class="h3">
          Obtaining and interpreting histopathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         For histopathology, paraffin-embedded tissue from a biopsy of an affected organ is obtained. Microscopic evaluation of the tissue sample by a pathologist reveals variable findings based on the clinical syndrome as discussed in each syndrome-specific topic:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease", section on 'Histopathology'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5517.html" rel="external">
          "Bartonella quintana infections: Clinical features, diagnosis, and treatment", section on 'Confirming the diagnosis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">
          "Endocarditis caused by Bartonella", section on 'Histopathology'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">
          "Bartonella infections in people with HIV", section on 'Diagnostic approach'
         </a>
         .) (for bacillary angiomatosis and for bacillary peliosis hepatis and splenitis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5516.html" rel="external">
          "South American bartonellosis: Oroya fever and verruga peruana", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2511780067">
         <span class="h3">
          Warthin-Starry staining
         </span>
         <span class="headingEndMark">
          —
         </span>
         If possible, WS silver staining of biopsied tissue should be performed.
        </p>
        <p>
         A positive WS stain is strongly suggestive of active infection but is not definitive and can be positive with other pathogens. The stain was originally developed to detect spirochetes, specifically
         <em>
          Treponema pallidum
         </em>
         (syphilis). It can also detect other spirochetes (eg,
         <em>
          Borrelia
         </em>
         ,
         <em>
          Helicobacter
         </em>
         ,
         <em>
          Leptospira
         </em>
         ), other small bacilli (eg,
         <em>
          Bartonella
         </em>
         ,
         <em>
          Campylobacter
         </em>
         ,
         <em>
          Legionella
         </em>
         ,
         <em>
          Tropheryma whipplei
         </em>
         [Whipple's disease],
         <em>
          Nocardia
         </em>
         ), and microsporidia. Spirochetes, such as
         <em>
          T.
         </em>
         <em>
          pallidum
         </em>
         and
         <em>
          Borrelia
         </em>
         <em>
          burgdorferi
         </em>
         , can easily be distinguished from
         <em>
          Bartonella
         </em>
         organisms based on morphology. In addition, the disorders caused by these pathogens can usually be differentiated from
         <em>
          Bartonella
         </em>
         infection based on the patient's history and clinical manifestations.
        </p>
        <p>
         With WS staining,
         <em>
          Bartonella
         </em>
         bacteria will appear as masses of small dark-staining bacilli typically with a golden-yellow background  (
         <a class="graphic graphic_picture graphicRef62100" href="/z/d/graphic/62100.html" rel="external">
          picture 1
         </a>
         ). The
         <em>
          Bartonella
         </em>
         organisms usually have a similar appearance regardless of the clinical syndrome, but they are more likely to be visualized, and in larger numbers, for certain syndromes (eg, bacillary angiomatosis). Interpretation of the test requires experienced laboratory personnel because debris can sometimes make the test appear positive. Gram stains do not reveal
         <em>
          Bartonella
         </em>
         organisms.
        </p>
        <p class="headingAnchor" id="H2202278952">
         <span class="h2">
          Polymerase chain reaction
         </span>
         <span class="headingEndMark">
          —
         </span>
         PCR tests are increasingly used to diagnose
         <em>
          Bartonella
         </em>
         infections because they have become more available and are less challenging to perform by laboratory personnel than other definitive methods of diagnosis [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
         Multiple commercial laboratories offer PCR testing, as does the United States Centers for Disease Control and Prevention (CDC) [
         <a href="#rid14">
          14
         </a>
         ]. Some commercial labs offer PCR tests that differentiate
         <em>
          B.
         </em>
         <em>
          henselae
         </em>
         from
         <em>
          B.
         </em>
         <em>
          quintana
         </em>
         [
         <a href="#rid15">
          15
         </a>
         ]
         <em>
          .
         </em>
         Results from the CDC may take longer (several weeks to months) for molecular testing compared with some private laboratories [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H720946020">
         <span class="h3">
          Obtaining samples for PCR
         </span>
         <span class="headingEndMark">
          —
         </span>
         PCR for
         <em>
          Bartonella
         </em>
         can be performed on blood, body fluids, and tissue samples.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Blood samples
         </strong>
         – PCR testing can be done on whole blood, plasma, or serum samples. Each commercial lab that offers PCR testing has specific instructions for determining the appropriate blood sample and tube for their test.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tissue samples
         </strong>
         – Tissue samples for PCR testing are obtained via biopsy (see
         <a class="local">
          'Optimal specimens'
         </a>
         above). Although fresh frozen tissue is preferred for PCR, the test can also be performed on paraffin-embedded tissue.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bodily fluids other than blood
         </strong>
         – Some labs offer PCR testing on fluids other than blood (eg, ocular fluid, cerebrospinal fluid). (See
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease", section on 'Neuroretinitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The appropriate sample type to be sent for PCR varies by clinical syndrome, and details can be found elsewhere. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H700908145">
         <span class="h3">
          Interpreting PCR results
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since PCR tests for
         <em>
          Bartonella
         </em>
         have high specificity, a positive PCR result is diagnostic of
         <em>
          Bartonella
         </em>
         infection in the appropriate clinical setting. Depending on the laboratory used, a positive PCR test may not be able to differentiate
         <em>
          B. henselae
         </em>
         from
         <em>
          B. quintana
         </em>
         .
        </p>
        <p>
         A negative PCR test cannot rule out bartonellosis because PCR tests for
         <em>
          Bartonella
         </em>
         may have suboptimal sensitivity. Multiple variables can affect the test's sensitivity including the suspected underlying clinical syndrome (eg, endocarditis, cat-scratch disease) and factors related to tissue sampling (eg, type, timing, and amount of collected specimen and whether the specific area sampled contained active disease). Information about the sensitivity of PCR for individual bartonellosis syndromes can be found elsewhere. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above.)
        </p>
        <p>
         If clinical suspicion remains high despite a negative PCR test, other diagnostic techniques should be employed, as described elsewhere in this topic. (See
         <a class="local">
          'Serologic tests'
         </a>
         above and
         <a class="local">
          'Histopathology'
         </a>
         above and
         <a class="local">
          'Culture'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H28105036">
         <span class="h2">
          Culture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although a positive culture for
         <em>
          Bartonella
         </em>
         provides definitive evidence of active infection, the utility of culture is limited as a diagnostic test due to difficulties growing the organism using standard microbiology techniques [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1699892517">
         <span class="h3">
          Obtaining and processing samples for culture
         </span>
         <span class="headingEndMark">
          —
         </span>
         When obtaining samples to culture
         <em>
          Bartonella
         </em>
         , it is important to proactively communicate with microbiology laboratory personnel so they can optimize culture techniques and can extend the incubation period for a minimum of 28 days.
        </p>
        <p>
         Cultures can be attempted using either blood or fresh-biopsied tissue samples. The optimal sample to send for culture depends on the specific clinical syndrome. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Blood cultures
         </strong>
         – When sending blood cultures for suspected
         <em>
          Bartonella
         </em>
         , clinicians should confer with the microbiology laboratory to ensure that blood specimens are appropriately collected and processed. In most cases, blood samples for
         <em>
          Bartonella
         </em>
         should be collected directly into tubes containing ethylenediaminetetraacetic acid (EDTA). Once received in the lab, the EDTA tubes should undergo lysis centrifugation and then be plated onto agar.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Standard blood culture bottles (eg, BACTEC bottles) generally have low yield for
         <em>
          Bartonella
         </em>
         , although the organism has occasionally been cultured on agar from samples obtained from unincubated BACTEC bottles. If BACTEC bottles are incubated in an automated CO
         <sub>
          2
         </sub>
         detection system,
         <em>
          Bartonella
         </em>
         growth will typically not trigger an alert. However, the organism has been isolated by subculturing samples from blood culture bottles that have been incubated for eight days; in these cases, acridine orange staining of the incubated blood prior to subculturing has been shown to reveal organisms in most infected antibiotic-naïve individuals [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tissue samples
         </strong>
         – Fresh tissue is generally preferred for cultures. Discussion with the microbiology and histopathology department prior to obtaining samples can ensure that appropriate samples are collected and directly submitted for culturing prior to placement in formalin. Once received in the microbiology lab, the tissue sample should be minced and then homogenized.
        </p>
        <p>
        </p>
        <p>
         Processed samples should be plated onto fresh agar plates that were created within seven days of use. One plate should contain chocolate agar (to optimize isolation of
         <em>
          B. quintana
         </em>
         ) and another plate should contain heart-infusion agar (to optimize isolation of
         <em>
          B. henselae
         </em>
         ). The heart-infusion agar plate should be
         <em>
         </em>
         supplemented with 5 percent rabbit blood because
         <em>
          Bartonella
         </em>
         species require heme for growth [
         <a href="#rid18">
          18
         </a>
         ]. Commercial sheep or horse blood agar have also been used, but these mediums may be less sensitive. Once plated, samples should be incubated at 35°C with 5 percent CO
         <sub>
          2
         </sub>
         and high humidity for a minimum of 28 days. If growth of colonies is detected, subcultures should be performed and should be incubated for seven days [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4257456270">
         <span class="h3">
          Interpreting culture results
         </span>
         <span class="headingEndMark">
          —
         </span>
         A positive culture for
         <em>
          Bartonella
         </em>
         from blood or tissue is definitive evidence of active infection.
        </p>
        <p>
         However, a negative culture does not rule out infection. The sensitivity of culture as a diagnostic test for
         <em>
          Bartonella
         </em>
         is hampered by laboratory difficulties associated with growing the organism. If clinical suspicion remains high despite negative culture results, alternative means of diagnosis should be pursued, as described above. (See
         <a class="local">
          'Serologic tests'
         </a>
         above and
         <a class="local">
          'Histopathology'
         </a>
         above and
         <a class="local">
          'Polymerase chain reaction'
         </a>
         above.)
        </p>
        <p>
         <strong>
          SOCIETY GUIDELINE LINKS
         </strong>
         — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111612.html" rel="external">
          "Society guideline links: Opportunistic infections in adults with HIV"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28105092">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach to diagnosis
         </strong>
         –
         <em>
          Bartonella henselae
         </em>
         and
         <em>
          Bartonella quintana
         </em>
         cause multiple distinct clinical syndromes, and the approach to diagnostic testing varies by syndrome. With the exception of cat-scratch disease, the microbiologic diagnosis usually requires serologic testing combined with one or more definitive nonserologic tests. For cat-scratch disease, the diagnosis is typically based on a characteristic clinical presentation coupled with a history of cat or flea exposure, with serologic testing mainly used to support the diagnosis. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Serologic tests
         </strong>
         – Serologic testing is not a definitive test for
         <em>
          Bartonella
         </em>
         infection, but it is often used as an initial test to raise or lower the suspicion of infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A positive serologic test is generally defined as a titer ≥1:256, except for endocarditis, which typically has higher titers. When a definitive nonserologic test cannot be performed, a positive serologic test coupled with strong clinical suspicion is often used to make a presumptive diagnosis of
         <em>
          Bartonella
         </em>
         infection. (See
         <a class="local">
          'Serologic tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A negative (&lt;1:64) IgG result substantially reduces the likelihood of bartonellosis. If clinical suspicion remains high despite a negative or equivocal (eg, 1:64 and 1:128) IgG, repeat serologic testing can provide further clarification; the timing of repeat testing depends on the syndrome and underlying clinical suspicion for disease. (See
         <a class="local">
          'Negative or equivocal IgG results'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitive tests
         </strong>
         – A positive definitive test confirms the diagnosis in the appropriate clinical setting. (See
         <a class="local">
          'Definitive diagnostic tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Histopathology
         </strong>
         – Histopathologic findings from tissue samples vary based on the clinical syndrome. A positive Warthin-Starry (WS) stain on tissue (masses of small dark-staining bacilli with a golden-yellow background) can further support the diagnosis of
         <em>
          Bartonella
         </em>
         infection. (See
         <a class="local">
          'Histopathology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Polymerase chain reaction
         </strong>
         – These tests have become more available and are less challenging for the laboratory to perform than other definitive tests, such as WS staining or culture. The test can be performed on body fluids (including blood) and biopsied tissue, depending on the clinical syndrome. A positive polymerase chain reaction (PCR) test is diagnostic of infection. (See
         <a class="local">
          'Polymerase chain reaction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Culture
         </strong>
         – Cultures of blood or tissue can
         <em>
         </em>
         provide definitive evidence of active infection, but their utility is limited due to difficulties growing
         <em>
          Bartonella
         </em>
         by standard microbiology techniques and the time typically required for the organism to grow. (See
         <a class="local">
          'Culture'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2366550090">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed as Section Editor on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Houpikian P, Raoult D. Western immunoblotting for Bartonella endocarditis. Clin Diagn Lab Immunol 2003; 10:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edouard S, Nabet C, Lepidi H, et al. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol 2015; 53:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regnery RL, Olson JG, Perkins BA, Bibb W. Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet 1992; 339:1443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alattas NH, Patel SN, Richardson SE, et al. Pediatric Bartonella henselae Infection: The Role of Serologic Diagnosis and a Proposed Clinical Approach for Suspected Acute Disease in the Immunocompetent Child. Pediatr Infect Dis J 2020; 39:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vermeulen MJ, Verbakel H, Notermans DW, et al. Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology. J Med Microbiol 2010; 59:743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yakubovsky M, Golan Y, Guri A, et al. Misleading Positive Serology for Cat Scratch Disease following Administration of Intravenous Immunoglobulin. Pathogens 2022; 11.
          </a>
         </li>
         <li class="breakAll">
          Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf (Accessed on March 04, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koehler JE, Sanchez MA, Tye S, et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis 2003; 37:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Comer JA, Flynn C, Regnery RL, et al. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med 1996; 156:2491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergmans AM, Peeters MF, Schellekens JF, et al. Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol 1997; 35:1931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dupon M, Savin De Larclause AM, Brouqui P, et al. Evaluation of serological response to Bartonella henselae, Bartonella quintana and Afipia felis antigens in 64 patients with suspected cat-scratch disease. Scand J Infect Dis 1996; 28:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeaiter Z, Fournier PE, Greub G, Raoult D. Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum. J Clin Microbiol 2003; 41:919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diaz MH, Bai Y, Malania L, et al. Development of a novel genus-specific real-time PCR assay for detection and differentiation of Bartonella species and genotypes. J Clin Microbiol 2012; 50:1645.
          </a>
         </li>
         <li class="breakAll">
          Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. National Institutes of Health. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/bartonellosis-0 (Accessed on January 26, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen WA, Fall MZ, Rooney J, et al. Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J Clin Microbiol 2000; 38:1717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gutiérrez R, Vayssier-Taussat M, Buffet JP, Harrus S. Guidelines for the Isolation, Molecular Detection, and Characterization of Bartonella Species. Vector Borne Zoonotic Dis 2017; 17:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larson AM, Dougherty MJ, Nowowiejski DJ, et al. Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol 1994; 32:1492.
          </a>
         </li>
         <li class="breakAll">
          Dumler JS, Carroll KC, Patel R. Bartonella. In: Manual of Clinical Microbiology, 12th ed, Carroll KC, Pfaller MA, Landry ML, et al (Eds), Wiley, 2019.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 16504 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12522046" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Western immunoblotting for Bartonella endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25540398" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Bartonella, a common cause of endocarditis: a report on 106 cases and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1351130" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32826721" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Pediatric Bartonella henselae Infection: The Role of Serologic Diagnosis and a Proposed Clinical Approach for Suspected Acute Disease in the Immunocompetent Child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20223899" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35215121" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Misleading Positive Serology for Cat Scratch Disease following Administration of Intravenous Immunoglobulin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35215121" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Misleading Positive Serology for Cat Scratch Disease following Administration of Intravenous Immunoglobulin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12905141" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8944742" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9230358" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8893399" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Evaluation of serological response to Bartonella henselae, Bartonella quintana and Afipia felis antigens in 64 patients with suspected cat-scratch disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12624010" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22378904" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Development of a novel genus-specific real-time PCR assay for detection and differentiation of Bartonella species and genotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22378904" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Development of a novel genus-specific real-time PCR assay for detection and differentiation of Bartonella species and genotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10790087" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Rapid identification and differentiation of Bartonella species using a single-step PCR assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28055575" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Guidelines for the Isolation, Molecular Detection, and Characterization of Bartonella Species.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7521357" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7521357" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15155180" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Recommendations for treatment of human infections caused by Bartonella species.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
